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1607-551X/Copyright ª 2015, KaohsiuAbstract We conducted this study to report on our initial experience and assess the safety,
feasibility, and efficacy of extraperitoneal single plus one port laparoscopic radical prostatec-
tomy (SPOPL-RP), and determine whether it shows any objective advantage over standard
laparoscopic radical prostatectomy. From June 2009 to September 2011, 15 extraperitoneal
SPOPL-RPs were performed through a 2e3-cm subumbilical longitudinal incision and another
5-mm trocar placed at the McBurney point. This cohort was compared with 37 contemporary
patients who underwent standard extraperitoneal laparoscopic radical prostatectomy per-
formed by the same urologist. Peri- and postoperative outcomes, including continence, po-
tency, and scar length, were statistically analyzed. The two groups were comparable with
respect to patient demographics, estimated blood loss, drainage time, duration of catheteri-
zation, catheterization rate >14 days, complication rate, postoperative hospitalization, and
postoperative functional and oncologic outcomes (p > 0.05). The SPOPL-RP procedures had
a longer mean operative time (170.1 minutes vs. 139.5 minutes, p Z 0.005), but with fewer
patients requiring analgesics (20% vs. 54.1%, p Z 0.038) and earlier resumption of oral intake
(20.7 hours vs. 26.8 hours, pZ 0.037). The mean scar length in the SPOPL-RP group was much
smaller (3.4 cm vs. 5.8 cm, p Z 0.000) owing to the significant reduction of the skin incision.eclare no conflicts of interest.
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SPOPL-RP versus standard LRP for PCa 345The peri- and postoperative outcomes of SPOPL-RP for low-risk prostate cancer are compara-
ble to those with the standard laparoscopic approach. In addition, SPOPL-RP provides better
postoperative pain control, faster recovery of bowel function, and smaller scar length than
standard laparoscopy, albeit with a longer operative time.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Transperitoneal and extraperitoneal laparoscopic radical
prostatectomy (LRP) have become the standard treatment
for local prostate cancer (PCa) because of their minimal
invasiveness, comparable operative duration, satisfactory
pain control, short hospital stay, and quick postoperative
convalescence [1e3]. Given the ongoing trend toward
minimal invasiveness in urologic surgery, single-port lapa-
roscopy (SPL) aims to further reduce the limited invasive-
ness of conventional laparoscopy and, at the same time,
offer an even better cosmetic outcome and quicker post-
operative convalescence with little pain [4]. However, SPL
remains a challenging surgical technique mainly because of
the lack of triangulation among the surgical instruments.
Proper laparoscopic suturing techniques and considerable
surgical skills are required for procedures such as radical
prostatectomy, and proper suturing is mandatory to
adequately complete the vesicourethral anastomosis.
Meanwhile, there is a lack of sufficient scientific data to
confirm whether this advanced technique is objectively
superior to conventional laparoscopy.
In this 2-year retrospective cohort, we compared single
plus one port laparoscopic radical prostatectomy (SPOPL-
RP) using the strategy of gaining multi-instrument access
through a single port with standard laparoscopies in an
attempt to determine whether SPOPL had any objective
advantage over standard laparoscopies with respect to
perioperative outcomes and follow-up data.Patients and methods
Study design and patients
In this retrospective case-control study, we compared pa-
tients who underwent either SPOPL-RP or standard LRP
beginning with our initial SPOPL-RP case in June 2009. Be-
tween June 2009 and September 2011, a total of 96 LRP
procedures were performed by a single surgeon (Dr Danfeng
Xu). Patients who had received preoperative pharmaco-
therapy, radiotherapy preoperatively, or intraoperative
positive lymph node were excluded.
Indications for LRP were generally the same as those for
open prostatectomy, and patients with clinical stage
T1ce2c PCa with a life expectancy of >10 years were
candidates for LRP. Preoperative computed tomography
and magnetic resonance imaging examinations of the pelvic
cavity showed no sign of metastasis, and radionuclide bonescans showed no bone metastasis in any of the included
patients.
Of the 96 patients, we identified 81 patients who were
treated with standard LRP and 15 patients who were
treated with SPOPL-RP for early stage local PCa. The peri-
operative and 24-month follow-up outcomes of the SPOPL
group (n Z 15) were compared with the outcomes of 37
matched patients who were treated with standard LRP
during the same period. Patients in the two groups were
matched retrospectively on the basis of patient age, body
mass index (BMI), American Society of Anesthesiologists
score, preoperative serum prostate specific antigen (PSA)
value, Gleason score, prostate size, preoperative conti-
nence, potency, and clinical tumor stage (cT1cecT2b).
Patients were treated with either standard LRP or SPOPL-RP
according to the clinical judgment of the surgeon. Criteria
for SPOPL-RP that could provide surgeons with the deciding
factors included local PCa in a relatively early stage
(cT1cecT2b), preoperative serum PSA value < 20, Gleason
score < 7 and primary Gleason score < 3, relatively low BMI
(<30), and no previous abdominal surgery. Meanwhile, pa-
tients with PCa at clinical stage > T2b, distant metastasis,
serious comorbid disease, and that have been followed up
for <1 year were excluded. Patients were informed that
additional incisions or open surgical conversions might be
warranted during the procedure. All patients provided
informed consent.
Perioperative outcomes and follow-up data
Patient demographics and perioperative data were
reviewed, including operative time, estimated blood loss,
transfusion rate, pre- and postoperative serum levels of
hemoglobin, surgical conversions, analgesic requirement,
time off of oral intake, scar length, drainage and cathe-
terization time, pathologic results, positive surgical margin
(PSM) rate and the location of þSM, postoperative hospi-
talization length, intra- and postoperative complications
(according to the Clavien grading system [5]), pre- and
postoperative continence and potency rate, and short- to
intermediate-term follow-up data. PSA and correlative
image examinations after RP were carried out quarterly
during the 1st year and semiannually during the 2nd year.
Pre- and postoperative evaluations of continence and
potency were performed in 52 patients using the Interna-
tional Continence Society questionnaire and the Interna-
tional Index of Erectile Function along with Sexual
Encounter Profile (SEP) diaries. Potency and continence
data were recorded at 3 months, 6 months, 12 months, and
24 months after the procedure. Patients not requiring any
346 D.-X. Zhang et al.pads or those who required one pad for safety were defined
as continent. A requirement for two to three pads daily in
patients with normal physical activity (walking) was
considered “mild incontinence”, and that for more than
three pads daily was deemed “incontinence”. Patients who
responded positively to the following SEP diary questions
were defined as potent regardless of whether PDE-5 in-
hibitors were useddSEP2: “Were you able to insert your
penis into your partner’s vagina?”; SEP3: “Did your erec-
tions last long enough to have sexual intercourse?”; and
SEP5: “Were you satisfied with this sexual experience?” [6].
Surgical techniques of SPOPL-RP and standard LRP
The techniques of SPOPL-RP and standard LRP have been
previously reported in detail in our article published in the
Chinese Medical Journal (English edition) [7]. The main
multiple instrument access port (including one 10-mm and
two 5-mm trocars) was placed in the subumbilical via a 2.5-
cm longitudinal incision (Fig. 1A). This port was applied to
insert major surgical instruments to carry out the opera-
tion. An additional port (one 5-mm trocar) was made at the
McBurney point (Fig. 1B) to allow the assistant to help the
operator, to reduce single-port laparoscopic operational
difficulties, and for postoperative drainage. No posterior
bladder neck reconstruction was undertaken during the
procedure in our two groups of patients. No routine bilat-
eral lymph node dissection was performed during RP in
patients at low risk for lymph node metastasis
(PSA < 10 ng/mL and biopsy Gleason Score (GS) < 7)
Statistical analysis
The two groups were analyzed using ManneWhitney and
Chi-square tests for continuous and categorical variables.
Statistical significance was set at p < 0.05, and all reported
p values were two-sided. Statistical analyses were per-
formed using SPSS v. 18.0 (SPSS, Inc., Chicago, IL, USA).Figure 1. Postoperative wounds: (A) the main multi-
instrument access port and (B) the additional port.Results
The preoperative patient characteristics are shown in Table
1. The patient demographics were comparable between the
two groups with respect to patient age, BMI, American So-
ciety of Anesthesiologists classification, serum PSA, highest
Gleason biopsy, prostate size, clinical tumor stage, preop-
erative potency, and continence.
Surgical characteristics, pathologic outcomes, and follow-
up data are presented in Table 2. No surgical conversion was
required in either group. No significant difference was
observed in estimated blood loss, transfusion, postoperative
hemoglobin, drainage time, duration of catheterization,
catheterization rate >14 days, complication rate, length of
postoperative hospital stay, PSMs, pathological stage,
regional lymphnodemetastasis rate, biochemical-free status
rate, and postoperative potent and continent rate between
the SPOPL-RP and standard LRP groups. Compared with the
standard LRP, the SPOPL-RP procedures required a longer
mean operative time (170.1 minutes vs. 139.5 minutes,
pZ 0.005), but with fewer patients requiring analgesics (20%
vs. 54.1%, p Z 0.038) and earlier resumption of oral intake
(20.7 hours vs. 26.8 hours, pZ 0.037). The mean scar length
in the laparoendoscopic single-site (LESS) group was 3.4 cm
compared with 5.8 cm (for five scars) in the standard lapa-
roscopy group (pZ 0.000).
Transfusion was required in one case in the SPOPL-RP
group owing to hemorrhage from an inadvertent injury of
the lateral vascular pedicle of the prostate, and in two
cases in the standard LRP group (Clavien grade II) owing to
hemorrhage from the penile dorsal vascular complex, but
no surgical conversion was needed in any of these three
cases. Postoperative complications occurred in two pa-
tients in the SPOPL-RP group, including one patient with
anastomotic urine leakage (Clavien grade II) and one pa-
tient with minor wound infection (Clavien grade I). In the
standard laparoscopy group, anastomotic urine leakage
occurred in two cases (Clavien grade II), urinary retention
in one case (Clavien grade II), urethral stricture in one case
(Clavien grade II), and minor wound infection in one case
(Clavien grade I). Drainage, catheterization time, and
length of hospital stay were prolonged in three cases of
anastomotic urine leakage. Two cases of urethral stricture
and urinary retention were treated with weekly urethral
dilatation and catheterization. All postoperative compli-
cations were managed conservatively.
The continence results of both groups are indicated in
Table 3. In the SPOPL-RP group, 73.3% patients reported
continence (0e1 pads/d), 13.3% patients reported minimal
stress incontinence (2e3 pads/d), and 13.3% required >3
pads/d at 3 months after surgery, in comparison with 70.3%,
21.6%, and 8.1%, respectively, in the standard LRP group
during the same period. At 6 months after surgery, 80% of
patients in the SPOPL-RP group and 81.2% of patients in the
standard LRP group reported continence. Mild stress in-
continence was observed in 20% of patients in the SPOPL-RP
group and in 13.5% of patients in the standard LRP group.
The percentage of incontinent patients in the SPOPL-RP and
standard LRP groups was 0% and 5.4% at 6 months,
respectively. Continence, mild incontinence, and inconti-
nence rates in the 12-month follow-up period were 93.3%,
Table 1 Patient demographics.
Parameter SPOPL-RP (n Z 15) Standard LRP (n Z 37) p
Age (y) 65.3  5.99 (56e77) 66.5  6.82 (53e77) NS
BMI (kg/m2) 23.4  2.43 (18.9e27.2) 23.2  2.65 (18e31.1) NS
Preoperative hemoglobin 142.6  11.81 (120e160) 139.1  11.64 (112e161) NS
ASA score NS
1 1 3
2 13 32
3 1 2
Serum PSA (ng/mL) 12.1  4.20 (6e20) 12.0  4.91 (5e20) NS
Highest Gleason biopsy 6.0  0.93 (4e7) 6.2  0.66 (5e7) NS
Prostate size (mL) 36.8  8.68 (26.5e59.3) 37.7  14.55(20.3e78.2) NS
Clinical tumor stage NS
T1c 10 23
T2a 4 12
T2b 1 2
Preoperative potency 12 (80) 29 (78.4) NS
Preoperative continence 15 (100) 37 (100) NS
Data are presented as n (%) or mean  SD (range).
ASAZ American Society of Anesthesiologists; BMIZ body mass index; LRPZ laparoscopic radical prostatectomy; NSZ not significant;
PSA Z prostatic specific antigen; SD Z standard deviation.
SPOPL-RP versus standard LRP for PCa 3476.7%, and 0%, respectively, for patients undergoing SPOPL-
RP versus 86.5%, 10.8%, and 2.7%, respectively, for patients
undergoing standard LRP. There were no incontinent pa-
tients at 24 months after surgery in either group, however,Table 2 Surgical characteristics, pathologic outcomes, and foll
Parameter SPOPL-RP (n Z 15
OT (min) 170.1  31.78 (125e
EBL (mL) 100.7  43.8 (50e20
Conversion (n) 0
Postoperative hemoglobin 132.7  10.39 (107e
Time to oral intake (h) 20.7  6.37 (14e40)
Analgesic requirement 3 (20)
LOS (d) 7.3  3.06 (5e17)
Scar length (cm) 3.4  0.35 (3e4)
Transfusion 1 (6.7)
Complication 2 (13.3)a
Drainage time (d) 5.7  3.13 (3e15)
Duration of catheterization (d) 10.4  3.29 (7e20)
Catheterization >14 d 0 (0)
Positive surgical margins 2 (13.3)
Pathological stage
T2a 9
T2b 3
T2c 2
T3a 1
Regional lymph node metastasis 0
Biochemical free status
3 mo p.o. 15 (100)
6 mo p.o. 15 (100)
12 mo p.o. 14 (93.3)
24 mo p.o. 14 (93.3)
Data are presented as n (%) or mean  SD (range).
EBLZ estimated blood loss; LOSZ length of stay; NSZ not significan
specific antigen; SD Z standard deviation; SPOPL-RP Z single plus on
a Anastomotic urine leakage (1), minor wound infection (1).
b Anastomotic urine leakage (2), urinary retention (1), urethral stricone patient in the SPOPL-RP group required 2e3 pads/d and
three patients in the standard LRP group required 2e3
pads/d. No statistical significance was observed between
the two groups.ow-up data.
) Standard LRP (n Z 37) p
240) 139.5  39.52 (80e250) 0.005
0) 100.3  109.30(40e600) NS
0 NS
144) 131.7  12.73 (99e163) NS
26.8  11.63 (14e50) 0.037
19 (51.4) 0.038
7.0  3.16 (5e20) NS
5.8  0.46 (5e7) < 0.001
2 (5.4) NS
5 (13.5)b NS
5.6  3.57(2e20) NS
11.1  3.79 (7e21) NS
1 (2.7) NS
6 (16.2) NS
NS
17
9
7
4
0 NS
37 (100) NS
36 (97.3) NS
36 (97.3) NS
35 (94.6) NS
t; p.o.Z postoperatively; OTZ operation time; PSAZ prostatic
e port laparoscopic radical prostatectomy.
ture (1), minor wound infection (1).
Table 3 Short-term comparison of continence and po-
tency outcomes.
Parameter SPOPL-RP
(n Z 15)
Standard LRP
(n Z 37)
p
Continence 11 (73.3) 26 (70.3)
Mild
incontinence
2 (13.3) 8 (21.6)
Incontinence 2 (13.3) 3 (8.1)
3 mo p.o. NS
Continence 12 (80) 30 (81.2)
Mild
incontinence
3 (20) 5 (13.5)
Incontinence 0 2 (5.4)
6 mo p.o. NS
Continence 14 (93.3) 32 (86.5)
Mild
incontinence
1 (6.7) 4 (10.8)
Incontinence 0 1 (2.7)
12 mo p.o. NS
Continence 14 (93.3) 34 (91.9)
Mild
incontinence
1 (6.7) 3 (8.1)
Incontinence 0 0
24 mo p.o. NS
Potency
3 mo p.o. 5 (33.3) 11 (29.7) NS
6 mo p.o. 6 (40) 16 (43.2) NS
12 mo p.o. 8 (53.3) 19 (51.4) NS
24 mo p.o. 9 (60) 23 (62.2) NS
Data are presented as n (%).
LRP Z laparoscopic radical prostatectomy; NS Z not signifi-
cant; p.o. Z postoperatively; SPOPL-RP Z single plus one port
laparoscopic radical prostatectomy.
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standard LRP groups was 34.5  8.58 (range 24e51) months
and 34.4  7.12 (range 25e50) months, respectively.
Erectile function sufficient for intercourse with or without
the help of PDE-5 inhibitors at 3 months, 6 months, 12
months, and 24 months was reported in 33.3%, 40%, 53.3%,
and 60%, respectively, of patients in the SPOPL-RP group,
compared with 29.7%, 43.2%, 51.4%, and 62.2%, respec-
tively, in the standard LRP group (Table 3). The difference
was not statistically significant.
The oncological data are presented in Table 2. Although
there were more patients with pT3a disease in the standard
LRP group compared with the SPOPL-RP group, the differ-
ence was not statistically significant. The overall PSM rate
was 13.3% in the SPOPL-RP group versus 16.2% in the stan-
dard LRP group; the difference was not statistically signif-
icant. The PSM was located in the apex in two patients and
in the posterolateral aspect in two patients from the
SPOPL-RP group. In the standard LRP group, the PSM was
located in the apex in three patients, and in the apex,
multiple sites, posterolateral aspect, and the base in each
of the three patients. All eight PSM patients received hor-
mone therapy thereafter. Regional lymph node metastasis
was negative in both groups. The 24-month biochemical-
free status rate (PSA < 0.2 ng/mL) was 93.3% in the
SPOPL-RP group and 94.6% in the standard LRP group withor without hormone therapy. No statistically significant
difference was found between the two groups.Discussion
When the first case of LRP was reported in 1997 in the
United States, it was considered unfeasible because of the
excessively long operating time [8]. In subsequent years,
however, minimally invasive surgery was soon shown to be
both reproducible and practical in Europe and became the
standard of care [9e11]. Since then, the LRP technique has
been widely accepted by more urologists, who report that
the resultant oncological control and functional recoveries
are comparable to those of open surgery performed in many
high-volume centers throughout the world [12,13].
Laparoscopic radical prostatectomy has become a well-
established alternative to open surgery [14]. Despite the
success with conventional LRP, incisions ranging from
0.5 cm to 3 cm and four or five trocars are strictly required,
although each incision runs the risk of potential port-
related complications. Efforts have been made to further
reduce minimally invasive surgery-associated morbidity.
SPL allows laparoscopic procedures to be performed
through a single incision using a multichannel port and
articulating instruments [15,16]. In urology, SPL has been
used to perform radical nephrectomy, partial nephrectomy,
donor nephrectomy, adrenalectomy, renal cryoablation,
pyeloplasty, ureteroneocystostomy, radical cystectomy,
varicocelectomy, prostatectomy, and robotic surgery
[17e21].
Kaouk et al. [22] first reported a series of four laparo-
scopic radical prostatectomies for early-stage PCa using a
single port in 2008. They used a multichannel port inserted
transperitoneally through a 1.8-cm umbilical incision. No
additional extraumbilical instrument or port was inserted,
and urethrovesical anastomosis was performed using free-
hand interrupted suturing and extracorporeal knot tying.
Their practice demonstrated that single-incision LRP is
feasible and efficacious, thus providing a prototype plat-
form for the evolution of natural orifice translumenal
endoscopic surgery. Since 2009, Dr Xu in our surgical team
has used SPOPL-RP in eight cases [7]. His practice was later
modified by Wen et al. [23], who recommended fixation of
the two ends of the suture thread using double Lapro-Clips
instead of the difficult knot tying. Since the introduction of
robotic-assisted laparoscopic surgery in urology, it has been
applied to LESS prostatectomy with initial pioneering
experience [18,24]. Despite the promising early outcomes,
the true benefits of single-port LRP compared with standard
laparoscopy are not clear, other than the subjective
cosmetic outcomes [25].
One related article reported by Akita et al. [26] made a
comparison between two-port (umbilicus and left iliac
fossa) laparoendoscopic and conventional five-port LRP and
found that the two-port RP was associated with shorter
operation time, less pain, shorter catheterization time, and
quicker recovery of continence. An overview of other arti-
cles concerning comparisons between single-port and
standard laparoscopic surgery in urology [20,27e29], in
combination with our own experience, shows the advantage
of SPOPL-RPda reduced need for postoperative analgesics,
SPOPL-RP versus standard LRP for PCa 349faster postoperative recovery of bowel function, and
smaller scar length. Although operative time in the SPOPL-
RP group was significantly longer than that in the standard
LRP, the mean operative time in our SPOPL-RP group was
significantly shorter than that reported in other studies
using the same extraperitoneal transumbilical procedure
[23,26,30e33], probably because we used another 5-mm
trocar under direct vision at the McBurney point. The
main limitation of single-port LRP is the reduced triangu-
lation, which may cause clashing of the instruments owing
to limited maneuverability, difficult visualization, and small
exposure of the operative field. From our initial experi-
ence, these technical issues with single-port LRP can be
partially resolved in our SPOPL-RP technique by placing
another 5-mm trocar at the McBurney point [7]. To date,
most comparative studies have shown a noninferiority of
LESS over conventional laparoscopy with respect to peri-
operative outcomes and revealed an encouraging tendency
toward decreased postoperative pain and better cosmesis
[26,34,35].
In the present study, we not only evaluated surgical
safety, surgical feasibility, perioperative outcomes, post-
operative functional outcomes, and oncologic outcomes,
but also pain, recovery, and scar length to assess the ad-
vantages of SPOPL-RP in this patient group. The results
have clearly demonstrated the advantages of SPOPL-RP,
including a reduced need for postoperative analgesics,
faster postoperative recovery of bowel function, and
smaller scar length. However, these benefits need to be
compared with the costs of technology.
Finally, this study is susceptible to all limitations
inherent in any retrospective study, and it is important to
recognize that LESS surgery is currently in an evolutionary
phase. Owing to the relatively small number of patients in
the SPOPL-RP cohort, even though we obtained statisti-
cally significant data, the actual benefits of SPOPL-RP
versus standard laparoscopy remain to be proven. In
addition, selection bias might still exist due to the clinical
judgment of the surgeon, although all patients met our
inclusion criteria. Furthermore, there are several subjec-
tive factors in our patient follow-up setup with respect to
postoperative continence, and the pads used for solving
daily urine incontinence in our study may be smaller than
those used in other series, which may explain why the
continence rate in our study was lower than that in other
series.Conclusion
The perioperative, postoperative functional, and oncologic
outcomes of extraperitoneal SPOPL-RP for early-stage and
local PCa are comparable with those in the standard lapa-
roscopic approach. SPOPL-RP has proven to be able to
provide better postoperative pain control, faster recovery
of bowel function, and smaller scar length compared with
standard laparoscopy, albeit with a longer operative time.
However, additional researchdincluding randomized
controlled trials with long-term follow-up periodsdis war-
ranted to draw solid conclusions regarding the clinical
validation of this procedure in comparison with standard
laparoscopic approaches.Acknowledgments
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